CFHealthHub Data Observatory
Details
- Therapeutic approach
- Behavioural
- Trial status
- Open to recruitment Participating Centres
- Trials Tracker ID
- TT001771
- Last updated
- 23/07/2020
CFHealthHub Data Observatory: A quality improvement project and Trials Within Cohort platform for Cystic Fibrosis
Study detailsCystic Fibrosis (CF) affects more than 10000 people in the UK. The lungs of people with CF (PWCF) are prone to infections and require daily medication to stay healthy. Average adherence to medication has been shown to be only 36%. Poor adherence is associated with poor clinical outcomes including distressing unscheduled hospitalisations. Previous research has been undertaken to design a website (CFHealthhub) which records personal adherence data using chipped nebulisers and understand whether this can build successful treatment habits.
In the current project we will develop CFHealthHub as a data observatory which will record adherence data and other indicators of health and patient care held in patient notes. The purpose of this is two- fold; to support local and national Quality Improvement (QI) projects aiming to increase an individual’s adherence to treatment and the quality of care delivered by the CF centre. Secondly, collecting adherence data from a large number of people with CF (PWCF) may support future research studies whereby CFHealthHub is used as a source of participants and data.
We aim to recruit PWCF who use chipped nebulisers from 17 CF centres across in England. PWCF will be consented to 1) share their identifiable data with their local CF team 2) share data, from which they cannot be identified, with all CF centres in the study 3) share data, from which they cannot be identified, in future research studies which result in no changes to their care and 4) share data to be included for selection to future studies which may result in changes to care, such as testing new treatments.
Consent in any combination can be provided and withdrawn at any time. Participants who consent to 'selection' for future studies will also be provided with information specific to the new study and the opportunity to decline participation, if selected from the data observatory.
- Phase
- Not applicable
- Length of participation
- >5 Years
- Recruitment target
- 2000
- CF sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- CF sponsor type
- Academic
Who can take part?
- Age range
- 16 years and older
- Including people
Diagnosed with CF and with data within the CF registry
Currently taking, or willing to take inhaled mucolytics or antibiotics via a chipped nebuliser and/or taking any form of medication for CF from which a Medicines Possession Ration (MPR) can be calculated.
Aged 16 years and above- Excluding people
Lacking in capacity to give informed consent
Get in touch